Retinoic acid activates interferon regulatory factor-1 gene expression in myeloid cells

Blood

Volumn 88, Issue 1, 1996, Pages 114-123

  Matikainen, Sampsa ^a   Ronni, Tapani ^b   Hurme, Mikko ^b   Pine, Richard ^b   Julkunen, Ilkka ^b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; GENE PRODUCT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; REGULATOR PROTEIN; RETINOIC ACID; TRANSCRIPTION FACTOR;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW CELL; CANCER INHIBITION; CHROMOSOME TRANSLOCATION 15; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; INTERFERON INDUCTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0029908573     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.1.114.114     Document Type: Article

References (57)

1. Chambon P: The molecular and genetic dissection of the retinoid signaling pathway. Gene 135:223, 1993
2. Grignani F, Fagioli M, Alcalay M, Longo L, Pandolfi PP, Donti E, Biondi A, Lo Coco F, Grignani F, Pelicci PG: Acute promyelocytic leukemia: From genetics to treatment. Blood 83:10, 1994
3. Warrel RP, Maslak P, Eardley A, Heller G, Miller WH, Frankel SR: Treatment of acute promyelocytic leukemia with all-trans retinoic acid: An update of the New York experience. Leukemia 8:929, 1994
4. Degos L, Dombret H, Chomienne C, Daniel M-T, Miclea J-M, Chastang C, Castaigne S, Fenaux P: All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. Blood 85:2643, 1995
5. Grignani F, Ferrucci PF, Testa U, Talamo G, Fagioli M, Alcalay M, Mencarelli A, Grignani F, Peschle C, Nicoletti I, Pelicci PG: The acute promyelocytic-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74:423, 1993
6. Rousselot P, Hardas B, Patel A, Guidez F, Gäken J, Castaigne S, Dejean A, de The H, Degos L, Farzaneh F, Chomienne C: The PML-RARα gene product of the t(15,17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells. Oncogene 9:545, 1994
7. Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valensi F, Berger R: NB4, a maturation inducible cell line with t(15; 17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 77:1080, 1991
8. Huang M, Ye YC, Chen BR, Chai JR, Lu JX, Zhoa L, Gu LJ, Wang ZY: Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72:567, 1988
9. Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, Fenaux P, Degos L: All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 76:1704, 1990
10. Warrel RP, Frankel SR, Miller WH, Scheinberg DA, Itri LM, Hittelman WN, Vyas R, Andreeff M, Tafuri A, Jakubowski A, Gabrilove J, Gordon MS: Differentiation therapy for acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 324:1385, 1991
11. Sen GC, Ransohoff RM: Interferon-induced antiviral actions and their regulation. Adv Virus Res 42:57, 1993
12. Borden EC: Interferons - expanding therapeutic roles. N Engl J Med 326:1491, 1992
13. Eisenhauer EA, Lippman SM, Cavanagh JJ, Parades-Espinoza M, Arnold A, Hong WK, Massimini G, Schleuniger U, Bollag W, Holdener EE, Krakoff I: Combination 13-cis-retinoic acid and interferon α-2a in therapy of solid tumors. Leukemia 8:1622, 1994
14. Rysiecki G, Gewert DR, Williams BRG: Constitutive expression of a 2′,5′-oligoadenylate synthetase cDNA results in increased antiviral activity and growth suppression. J Interferon Res 9:649, 1989
15. Meurs EF, Galabru J, Barber GN, Katze MG, Hovanessian AG: Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc Natl Acad Sci USA 90:2232, 1993
16. Hassel BA, Zhou A, Sotomayor CA: Dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon. EMBO J 12:3297, 1993
17. Lamphier M, Taniguchi T: The transcription factors IRF-1 and IRF2: Linking the interferon response and cell growth control. Immunologist 2:167, 1994
18. Veals SA, Schindler C, Leonard D, Fu X-Y, Aebersold R, Darnell J, Levy DE: Subunit of an alpha-interferon-responsive transcription factor is related to interferon regulatory factor and myb families of DNA-binding protein. Mol Cell Biol 12:3315, 1992
19. Willman CL, Sever CE, Pallavicini MG, Harada H, Tnaka N, Slovak ML, Yamamoto H, Harada K, Meeker TC, List AF, Taniguchi T: Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science 259:968, 1993
20. Boultwood J, Lewis S, Wainscoat JS: The 5q- syndrome. Blood 84:3253, 1994
21. Cantell K, Hirvonen S, Kauppinen H-L, Myllylä G: Production of interferon in human leukocytes from normal donors with the use of Sendai virus. Methods Enzymol 78:29, 1981
22. Cantell K, Hirvonen S, Kauppinen H-L: Production and partial purification of human immune interferon. Methods Enzymol 119:54, 1986
23. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294, 1979
24. Glisin V, Crkvenjankov R, Byus C: Ribonucleic acid isolated by cesium chloride centrifugation. Biochemistry 13:2633, 1974
25. Schwab M, Alitalo K, Varmus HE, Bishop JM, George DA: A cellular oncogene (c-Ki-ras) is amplified, overexpressed, and located within karyotypic abnormalities in mouse adrenocortical tumor cells. Nature 303:497, 1983
26. Maruyama M, Fujita T, Taniguchi T: Sequence of a cDNA coding for IRF-1. Nucleic Acids Res 17:3292, 1989
27. Benech P, Mory Y, Chebath J: Structure of two forms of the interferon-induced (2′-5′) oligo A synthetase of human cells based on cDNAs and gene sequences. EMBO J 4:2249, 1985
28. Ronni T, Sareneva T, Pirhonen J, Julkunen I: Activation of IFN-α, IFN-γ, MxA and IFN regulatory factor 1 genes in influenza A virus-infected human peripheral blood mononuclear cells. J Immunol 154:2764, 1995
29. Greenberg ME, Ziff EB: Stimulation of 3T3 cells induces transcription of c-fos proto-oncogene. Nature 311:433, 1984
30. Matikainen S, Tapiovaara H, Vaheri A, Hurme M: Activation of interleukin-1β gene expression during retinoic acid-induced granulocytic differentiation of promyeloid leukemia cells. Cell Growth Differ 5:975, 1994
31. Andrews NC, Faller DV: A rapid micropreparation technique for extraction of DNA-binding proteins from limited numbers of mammalian cells. Nucleic Acids Res 19:2499, 1991
32. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680, 1970
33. Collins SJ: The HL-60 promyelocytic leukaemia cell line: Proliferation, differentiation, and cellular oncogene expression. Blood 70:1233, 1987
34. Dalton WT, Ahearn MJ, McCredle KB, Freireich EJ, Stass SA, Trujillo JM: HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3. Blood 71:242, 1988
35. Auwerx J: The human leukemia cell line, THP-1: A multifaceted model for the study of monocyte-macrophage differentiation. Experientia 47:22, 1991
36. Matikainen S, Hurme M: Comparison of retinoic acid and phorbol ester as inducers of monocytic differentiation. Int J Cancer 57:98, 1994
37. Olsson IL, Breitman TR: Induction of differentiation of the human histiocytic lymphoma cell line U-937 by retinoic acid and cyclic 3′,5′-monophosphate-inducing agents. Cancer Res 42:3924, 1982
38. Pine R, Canova A, Schindler C: Tyrosine phosphorylated p91 binds to a single element in the ISGF2/IRF-1 promoter to mediate induction by IFNα and IFNγ, and is likely to autoregulate the p91 gene. EMBO J 13:158, 1994
39. Ihle JN: Cytokine receptor signaling. Nature 377:591, 1995
40. Raz R, Durbin JE, Levy DE: Acute phase response factor and additional members of the interferon-stimulated gene factor 3 family integrate diverse signals from cytokines, interferons, and growth factors. J Biol Chem 269:24391, 1994
41. Fujita T, Reis LFL, Watanabe N, Kimura Y, Taniguchi T, Vilcek J: Induction of the transcription factor IRF-1 and interferon-β mRNAs by cytokines and activators of second-messenger pathways. Proc Natl Acad Sci USA 86:9936, 1989
42. Harada H, Takahashi E-I, Itoh S, Harada K, Hori T-A, Taniguchi T: Structure and regulation of the human interferon regulatory factor 1 (IRF-1) and IRF-2 genes: Implications for a gene network in the interferon system. Mol Cell Biol 14:1500, 1994
43. Harada H, Kitakawa M, Tanaka N, Yamamoto H, Harada K, Ishihara M, Taniguchi T: Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science 259:971, 1993
44. Tanaka N, Ishihara M, Kitagawa M, Harada H, Kimura T, Matsuyama T, Lamphier MS, Aizawa S, Mak TW, Taniguchi T: Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell 77:829, 1994
45. Tamura T, Ishihara M, Lamphier MS, Tanaka N, Oishi I, Aizawa S, Matsuyama T, Taki S, Mak TW, Taniguchi T: An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature 376:596, 1995
46. Watanabe N, Sakakibara J, Hovanessian AG, Taniguchi T, Fujita T: Activation of IFN-beta element by IRF-1 requires a post-translational event in addition to IRF-1 synthesis. Nucleic Acids Res 19:4421, 1991
47. Sims SH, Cha Y, Romine MF, Gao P-Q, Gottlieb K, Deisseroth AB: A novel interferon-inducible domain: Structural and functional analysis of the human interferon regulatory factor 1 gene promoter. Mol Cell Biol 13:690, 1993
48. Sadowski HB, Shuai K, Darnell JE, Gilman MZ: A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science 261:1739, 1993
49. Zhong Z, Wen Z, Darnell JE: Stat3: A STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264:95, 1994
50. Harroch S, Revel M, Chebath J: Induction by interleukin-6 of interferon regulatory factor 1 (IRF-1) gene expression through the palindromic interferon response element pIRE and cell type-dependent control of IRF-1 binding to DNA. EMBO J 13:1942, 1994
51. Harada H, Fujita T, Miyamoto M, Kimura Y, Maruyama M, Furia A, Miyata T, Taniguchi T: Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58:729, 1989
52. Pine R, Decker T, Kessler DS, Levy DE, Darnell J: Purification and cloning of interferon-stimulated gene factor 2 (ISGF2): ISGF2 (IRF-1) can bind to the promoters of both beta interferon-and interferon-stimulated genes but is not a primary transcriptional activator of either. Mol Cell Biol 10:2448, 1990
53. Pine R: Constitutive expression of an ISGF2/IRF-1 transgene leads to interferon-independent activation of interferon-inducible genes and resistance to virus infection. J Virol 66:4470, 1992
54. Kimura T, Nakayama K, Penninger J, Kitakawa M, Harada H, Matsuyama T, Tanaka N, Kamijo R, Vilcek J, Mak TW, Taniguchi T: Involvement of the IRF-1 transcription factor in antiviral responses to interferons. Science 264:1921, 1994
55. Kamijo R, Harada H, Matsuyama T, Bosland M, Gerecitano J, Shapiro D, Le J, Koh SI, Kimura T, Green SJ, Mak TW, Taniguchi T, Vilcek J: Requirement for transcription factor IRF-I in NO synthase induction in macrophages. Science 263:1612, 1994
56. Briken V, Ruffner H, Schultz U, Schwartz A, Reis LFL, Strehlow I, Decker T, Staeheli P: Interferon regulatory factor 1 is required for mouse Gpb gene activation by gamma interferon. Mol Cell Biol 15:975, 1995
57. Cha Y, Deisseroth AB: Human interferon regulatory factor 2 gene. Intron-exon organization and functional analysis of 5′-flanking region. J Biol Chem 269:5279, 1994